Posts

Adherium secures A$13.5 million commitment in share and option placement

/in

Melbourne, Australia Link Here – 16 September 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments from the Company’s Chairman, new and existing institutional and sophisticated investors, including cornerstone investments from existing shareholders Trudell Medical and BioScience Managers Translation Fund […]

Read more

BioScience Managers calls time on the need for investors to join government to back Australia’s biotech and digital innovators

/in

1 April 2022: As leading healthcare investors, BioScience Managers welcomes the on-going bipartisan support for Australia’s developing biotechnology sector following the March Federal Budget. However, BioScience Managers is calling for greater backing from Australia’s investment community, particularly institutional investors, to retain the benefits of Australian innovation within Australia as a critical part our post COVID-19 pandemic recovery. […]

Read more

Canary Medical was named a Fast Company “Next Big Things in Tech” honoree

/in ,

These innovative projects are changing the health industry 05-03-2022   See the full list of honorees of Fast Company’s 2022 World Changing Ideas Awards in the health category. Link to full article

Read more